The gatekeepers of hES cell products
暂无分享，去创建一个
[1] Licensing fees slow advance of stem cells , 2005, Nature.
[2] Cyril R. Vidergar. Biomedical Patenting: Permitted, but Permissible? , 2003 .
[3] John O. Miller. A call to legal arms: bringing embryonic stem cell therapies to market. , 2003, Albany law journal of science & technology.
[4] A. Ligler. Egregious error or admirable advance: the memorandum of understanding that enables federally funded basic human embryonic stem cell research. , 2001, Duke law and technology review.